Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2005 025 738.1 |
96 | EP file number | EAKZ | 05 73 1600.2 |
86 | WO file number | WAKZ | PCT/US2005/008346 |
97 | EP publication number | EPN | 1725233 |
87 | WO publication number | WPN | 2005089757 |
54 | Designation/title | TI | PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND SNS-595 UND DEREN VERWENDUNGEN |
51 | IPC main class | ICM (ICMV) | A61K 31/44 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), A61P 35/02 (2006.01), A61K 38/18 (2006.01), A61K 9/00 (2006.01) |
22 | DE application date | DAT | Mar 14, 2005 |
96 | EP application date | EAT | Mar 14, 2005 |
86 | WO application date | WAT | Mar 14, 2005 |
43 | Date of first publication | OT | Sep 29, 2005 |
| Date of publication of grant | PET | Jan 5, 2011 |
71/73 | Applicant/owner | INH | Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, JP; Sunesis Pharmaceuticals, Inc., South San Francisco, Calif., US |
72 | Inventor | IN | HIGAKI, Masaru, Osaka-shi, Osaka, JP; NAKAO Satoshi, Osaka-shi, Osaka, 553-0001, JP |
74 | Representative | VTR | Jones Day Rechtsanwälte Patentanwälte, 80538 München, DE |
| Address for service | | JONES DAY Rechtsanwälte Attorneys-at-Law Patentanwälte, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 553578 P Mar 15, 2004
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001725233 Searchable text:
EP000001725233 Original document:
EP000001725233B1 Searchable text:
EP000001725233B1 Original document:
WO002005089757 Searchable text:
WO002005089757 |
43 | Date of first publication | EVT | Sep 29, 2005 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025 (Show all update days)(Hide all update days)- Jan 5, 2025
- Procedures: New representative details, New representative details, 26.11.2014: deleted
- Dec 24, 2019; Nov 19, 2019; Aug 21, 2019; Apr 10, 2019; Oct 25, 2018; Mar 8, 2018; Apr 11, 2017; Mar 14, 2017; Mar 18, 2016; Aug 25, 2015; Mar 26, 2015; Dec 31, 2014; Nov 27, 2014; Apr 29, 2014; Apr 8, 2014; Apr 10, 2013; Mar 20, 2013; Jan 29, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Dec 9, 2010 |
| Issue number | HN | 53 |
| Year | PJ | 2014 |
| Publication date | VT | Dec 31, 2014 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Dainippon Sumitomo Pharma Co., Ltd., Osaka, JP; Sunesis Pharmaceuticals, Inc., South San Francisco, Calif., US |
71/73 | Previous applicant/owner | INHF | Sunesis Pharmaceuticals, Inc., San Francisco, Calif., US |
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 26, 2014 |
| Issue number | HN | 53 |
| Year | PJ | 2014 |
| Publication date | VT | Dec 31, 2014 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, JP; Sunesis Pharmaceuticals, Inc., South San Francisco, Calif., US |
71/73 | Previous applicant/owner | INHF | Dainippon Sumitomo Pharma Co., Ltd., Osaka, JP, Sunesis Pharmaceuticals, Inc., South San Francisco, Calif., US |